Go Back
Axsome Therapeutics, Inc. reports $11.2 million Q1 loss
By USInMinutes - May 08, 2023, 08:26 AM ET
Last Updated - Jul 18, 2023, 03:34 PM EDT
The company generated $94.60 million in quarterly revenue
Axsome Therapeutics, Inc. [AXSM] has reported fiscal Q1 loss of $11.20 million.
On a per-share basis, the DE based company said its diluted earnings are $0.26.
The Pharmaceutical Preparations firm posted revenue of $94.60 million in this period.
Also Read:
- Axsome Therapeutics Reports First Quarter 2023 Financial Results and Corporate Update
- Axsome Therapeutics to Present at the Bank of America Securities 2023 Healthcare Conference
- Axsome Therapeutics Joins Mental Health America and the State of New York to Raise Awareness of ...
- Axsome Therapeutics to Present Five Abstracts Including New Data from the Positive SHARP Study ...
- Axsome Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News
